Uncategorized

The Future Market’s Financial NewsLetter – 4th Feb 2019

[jetpack_subscription_form show_only_email_and_button=”true” custom_background_button_color=”#362e77″ custom_text_button_color=”#ffffff” submit_button_text=”Subscribe” submit_button_classes=”wp-block-button__link has-text-color has-white-color has-background has-dark-blue-background-button-color” show_subscribers_total=”false” ]

financial-newsletter-670x335Corporate Financial Updates from The Future Market’s Watch Window on 4th Feb, 2019

[jetpack_subscription_form show_only_email_and_button=”true” custom_background_button_color=”#362e77″ custom_text_button_color=”#ffffff” submit_button_text=”Subscribe” submit_button_classes=”wp-block-button__link has-text-color has-white-color has-background has-dark-blue-background-button-color” show_subscribers_total=”false” ]

  • Exide Q3 net profit at Rs. 155 crore
    Net profit rose by 0.5% to Rs. 155 crore from Rs. 154.3 crore. Read More..
  • Insecticides Q3 net profit rises by 75.2% y-o-y
    Net profit rose by 75.2% to Rs. 16.9 crore from Rs. 9.6 crore. Read More..
  • Laurus Labs gets USFDA nod for HIV drug
    Laurus Labs received tentative approval from United States Food and Drug Administration (USFDA) under PEPFAR for Tenofovir/Lamivudine/Dolutegravir (TLD) 300/300/SOmg fixed dose combination (FDC). Read More..

To See more coprorate updates Click here…

DAILY MARKET INSIGHTS – 4th Feb 2019

Know why Reliance Communications shares have dropped 50% – 4th Feb 2019

4th Feb 2019 Stock Ideas – The Future Market’s watch window

STOCK IDEA’S for Feb-2019 by Sharekhan as on 1st Feb 2019

Indiabulls Housing Finance FY2019-Q3 net profit falls by 14% yoy – 31st Jan 2019

Quick Finance Updates

Leave a Reply